Medical Department and Clinical Trials
Become part of Roche’s medical success. Shape the future.
Roche continues its efforts to research and develop differentiated medicines and effective diagnostic tools in following therapeutic areas:
- Infectious diseases
As a company actively operating in both the diagnostic and pharmacy, we are pioneers in the field of "personalized medicine", which is located at the confluence of these two disciplines. Our personalized products, adjusted to the needs of specific groups of patients, are already available on the market.
In all of our business areas, e.g. in the field of biotechnology, we are actively setting new paths. We strongly believe that biotechnology is largely the key to innovation in the future, ranging from therapeutic proteins to the latest findings in the field of siRNA technology, biomarkers, translational medicine and bioinformatics.
These innovations have enabled us to effectively search for new therapeutic approaches, especially in the field of oncology. In recent years, our attention has been focused on the following technology platforms:
- synthesis and screening (UHTS, high-throughput screening)
- combinatorial chemistry
- three-dimensional modelling
- genetics, genomics
Our research teams have received many awards, including:
Nobel Prize in Physiology or Medicine:
- 1987, Susumu Tonegawa, Basel Institute of Immunology (BII), for his work on the genetic origins of antibodies diversity
- 1984, Niels Kaj Jerne, together with Georges Köhler, Basel Institute for Immunology (BII), and César Milstein, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom for the discovery of monoclonal antibodies
Prix Galien Awards (37 in total):
- 2013 USA Prix Galien for Zelboraf
- 2004 International Prix Galien for Fuzeon
- 1998 European Prix Galien for Invirase
- 1998 Prix Galien for Anexate
- 1992 International Prix Galien for Neupogen
You can help us to win another award.
Use your experience and perform important tasks at Roche to shape the future with us.